No Data
No Data
10-Q: Q3 2024 Earnings Report
8-K: Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
Avenue Therapeutics to Participate in Maxim Group's 2024 Healthcare Virtual Summit
Fortress Biotech Announces Pricing of $8 Million Registered Direct Offering and Concurrent Private Placements
Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference
Fortress Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference